“Giant cell arteritis manifesting as retinal arterial occlusion and paracentral acute middle maculopathy in a patient on pembrolizumab for metastatic uveal melanoma”
Author:
Publisher
Elsevier BV
Subject
Ophthalmology
Reference19 articles.
1. Ocular adverse events following use of immune checkpoint inhibitors for metastatic malignancies;Noble;Ocul Immunol Inflamm,2019
2. KEYNOTE-006 investigators. Pembrolizumab versus ipilimumab in advanced melanoma;Robert;N Engl J Med,2015
3. Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomized, controlled, phase 2 trial;Ribas;Lancet Oncol,2015
4. The use of pembrolizumab for the treatment of metastatic uveal melanoma;Kottschade;Melanoma Res,2016
5. Immune checkpoint inhibitor associated adverse events: a review of their presentations and treatments;Ye;Curr Treat Options Rheumatol,2019
Cited by 19 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Polymyalgia rheumatica and giant cell arteritis induced by immune checkpoint inhibitors: A systematic literature review highlighting differences from the idiopathic forms;Autoimmunity Reviews;2024-07
2. The Utility of Laboratory Investigations for the Assessment and Management of Rheumatic Immune Related Adverse Events;Rheumatic Disease Clinics of North America;2024-05
3. Update on Neuro-ophthalmic Manifestations of Immune Checkpoint Inhibitors;Current Neurology and Neuroscience Reports;2024-03-18
4. The Contribution of Innate Immunity in Large-Vessel Vasculitis: Detangling New Pathomechanisms beyond the Onset of Vascular Inflammation;Cells;2024-02-01
5. Retinal ischemic cascade: New insights into the pathophysiology and imaging findings;Survey of Ophthalmology;2023-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3